[Question] is 99.2% actually fine or am I being sold a rounding error
Title says it — is 99.2% actually fine or am I being sold a rounding error — so here is the boring supporting detail that makes it worth anything.
The relevant figures are 99.2%, and they come from the same log I have kept the whole time.
The system suitability argument, since it comes up whenever somebody posts a number without one.
Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.
None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.
Reading a trace posted here, in the order I actually look at things.
Axes first — if the wavelength and the time axis are not labelled, I stop. Then the baseline: where has it been drawn, and does the drawing absorb anything. Then peak shape: fronting, tailing, a shoulder that never resolves. Then the blank, if one was run, for carryover.
Only after all of that do I look at the percentage, and by then I usually know how much weight it deserves. The number is the last thing on the page and the first thing everybody argues about, which is exactly backwards.
Research-use-only material is not approved for human use and nothing here should be read as a recommendation to use it.
best — the order this archive was captured in
A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.
Not convinced by that integration. Dropping the baseline there absorbs part of the shoulder into the main peak.
Method questions stay here; supplier claims go to c/vendorvetting with a document attached.
UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.
Same method at both labs, or two different gradients?
Why two honest labs report different numbers on the same vial.
Start with the gradient. A shallower slope holds compounds on the column longer and usually separates close-eluting species better. A steeper one gets you a faster run and a fatter peak. If a related substance elutes near the main peak, one method resolves it and reports it separately, the other absorbs part of it into the main peak.
Then integration. Where the baseline is drawn under a shoulder is a decision made by a person or by a piece of software configured by a person. It moves the number.
A point or two of spread between services on this assay is ordinary. Treating one lab as ground truth is how people end up in arguments with suppliers that neither side can win.
Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.
baseline choice is a decision, not a measurement
retention time alone is not identity
Same view — reporting the gradient is what makes a result checkable rather than merely stated.
Correction: that is a tailing factor, not a plate count. Different diagnostics for different problems.
[removed by moderator]
This. A shoulder that does not baseline-resolve is a question, not a quantity.
Yes — system suitability first. Without it the number is an assertion about the instrument, not the sample.
report the method or do not report the number
Bought a second-hand instrument and learned more in six months of fixing it than in three years of reading traces.
Sent the same vial to VendorInvestigate and Janoshik. 99.0% against a claimed 98.5%. The difference was the gradient, not the material.
Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.
integration decisions move the number more than the sample does
Yes. Retention time is a hypothesis about identity. Mass is the answer.
What wavelength, and what was the gradient?
That is area percent, not mass percent. The trace cannot give you the second one.
Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.
Ran a blank after a high-concentration injection and found the carryover I had been calling an impurity.
- 1Yes. Retention time is a hypothesis about identity. Mass is the answer.7 comments in this branch · started by u/first_hundred